149 related articles for article (PubMed ID: 21842120)
1. Expression of LDL-A module of relaxin receptor in prostate cancer cells inhibits tumorigenesis.
Feng S; Agoulnik AI
Int J Oncol; 2011 Dec; 39(6):1559-65. PubMed ID: 21842120
[TBL] [Abstract][Full Text] [Related]
2. Relaxin drives Wnt signaling through upregulation of PCDHY in prostate cancer.
Thompson VC; Hurtado-Coll A; Turbin D; Fazli L; Lehman ML; Gleave ME; Nelson CC
Prostate; 2010 Jul; 70(10):1134-45. PubMed ID: 20503398
[TBL] [Abstract][Full Text] [Related]
3. Recombinant RXFP1-LDL-A module does not form dimers.
Petrie EJ; Periguini MA; Bathgate RA; Gooley PR
Ital J Anat Embryol; 2013; 118(1 Suppl):4-6. PubMed ID: 24640556
[TBL] [Abstract][Full Text] [Related]
4. Suppression of relaxin receptor RXFP1 decreases prostate cancer growth and metastasis.
Feng S; Agoulnik IU; Truong A; Li Z; Creighton CJ; Kaftanovskaya EM; Pereira R; Han HD; Lopez-Berestein G; Klonisch T; Ittmann MM; Sood AK; Agoulnik AI
Endocr Relat Cancer; 2010 Dec; 17(4):1021-33. PubMed ID: 20861284
[TBL] [Abstract][Full Text] [Related]
5. Identification of the N-linked glycosylation sites of the human relaxin receptor and effect of glycosylation on receptor function.
Yan Y; Scott DJ; Wilkinson TN; Ji J; Tregear GW; Bathgate RA
Biochemistry; 2008 Jul; 47(26):6953-68. PubMed ID: 18533687
[TBL] [Abstract][Full Text] [Related]
6. Resolving the unconventional mechanisms underlying RXFP1 and RXFP2 receptor function.
Hartley BJ; Scott DJ; Callander GE; Wilkinson TN; Ganella DE; Kong CK; Layfield S; Ferraro T; Petrie EJ; Bathgate RA
Ann N Y Acad Sci; 2009 Apr; 1160():67-73. PubMed ID: 19416161
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of relaxin receptor (LGR7/RXFP1) expression and function.
Kern A; Bryant-Greenwood GD
Ann N Y Acad Sci; 2009 Apr; 1160():60-6. PubMed ID: 19416160
[TBL] [Abstract][Full Text] [Related]
8. Ovarian cancer G protein-coupled receptor 1, a new metastasis suppressor gene in prostate cancer.
Singh LS; Berk M; Oates R; Zhao Z; Tan H; Jiang Y; Zhou A; Kirmani K; Steinmetz R; Lindner D; Xu Y
J Natl Cancer Inst; 2007 Sep; 99(17):1313-27. PubMed ID: 17728215
[TBL] [Abstract][Full Text] [Related]
9. The relaxin receptor (RXFP1) utilizes hydrophobic moieties on a signaling surface of its N-terminal low density lipoprotein class A module to mediate receptor activation.
Kong RC; Petrie EJ; Mohanty B; Ling J; Lee JC; Gooley PR; Bathgate RA
J Biol Chem; 2013 Sep; 288(39):28138-51. PubMed ID: 23926099
[TBL] [Abstract][Full Text] [Related]
10. Relaxin family peptide receptor (RXFP1) coupling to G(alpha)i3 involves the C-terminal Arg752 and localization within membrane Raft Microdomains.
Halls ML; van der Westhuizen ET; Wade JD; Evans BA; Bathgate RA; Summers RJ
Mol Pharmacol; 2009 Feb; 75(2):415-28. PubMed ID: 19029286
[TBL] [Abstract][Full Text] [Related]
11. The chemically synthesized human relaxin-2 analog, B-R13/17K H2, is an RXFP1 antagonist.
Hossain MA; Samuel CS; Binder C; Hewitson TD; Tregear GW; Wade JD; Bathgate RA
Amino Acids; 2010 Jul; 39(2):409-16. PubMed ID: 20043231
[TBL] [Abstract][Full Text] [Related]
12. Relaxin/RXFP1 signaling in prostate cancer progression.
Feng S; Agoulnik IU; Li Z; Han HD; Lopez-Berestein G; Sood A; Ittmann MM; Agoulnik AI
Ann N Y Acad Sci; 2009 Apr; 1160():379-80. PubMed ID: 19416223
[TBL] [Abstract][Full Text] [Related]
13. Roles of the receptor, the ligand, and the cell in the signal transduction pathways utilized by the relaxin family peptide receptors 1-3.
Summers RJ; Bathgate RA; Wade JD; van der Westhuizen ET; Halls ML
Ann N Y Acad Sci; 2009 Apr; 1160():99-104. PubMed ID: 19416167
[TBL] [Abstract][Full Text] [Related]
14. Progesterone withdrawal, and not increased circulating relaxin, mediates the decrease in myometrial relaxin receptor (RXFP1) expression in late gestation in rats.
Vodstrcil LA; Shynlova O; Westcott K; Laker R; Simpson E; Wlodek ME; Parry LJ
Biol Reprod; 2010 Nov; 83(5):825-32. PubMed ID: 20686183
[TBL] [Abstract][Full Text] [Related]
15. Relaxin becomes upregulated during prostate cancer progression to androgen independence and is negatively regulated by androgens.
Thompson VC; Morris TG; Cochrane DR; Cavanagh J; Wafa LA; Hamilton T; Wang S; Fazli L; Gleave ME; Nelson CC
Prostate; 2006 Dec; 66(16):1698-709. PubMed ID: 16998820
[TBL] [Abstract][Full Text] [Related]
16. Relaxin family peptide receptors Rxfp1 and Rxfp2: mapping of the mRNA and protein distribution in the reproductive tract of the male rat.
Filonzi M; Cardoso LC; Pimenta MT; Queiróz DB; Avellar MC; Porto CS; Lazari MF
Reprod Biol Endocrinol; 2007 Jul; 5():29. PubMed ID: 17623071
[TBL] [Abstract][Full Text] [Related]
17. Evidence for expression of relaxin hormone-receptor system in the boar testis.
Kato S; Siqin ; Minagawa I; Aoshima T; Sagata D; Konishi H; Yogo K; Kawarasaki T; Sasada H; Tomogane H; Kohsaka T
J Endocrinol; 2010 Nov; 207(2):135-49. PubMed ID: 20807724
[TBL] [Abstract][Full Text] [Related]
18. Expression of Frzb/secreted Frizzled-related protein 3, a secreted Wnt antagonist, in human androgen-independent prostate cancer PC-3 cells suppresses tumor growth and cellular invasiveness.
Zi X; Guo Y; Simoneau AR; Hope C; Xie J; Holcombe RF; Hoang BH
Cancer Res; 2005 Nov; 65(21):9762-70. PubMed ID: 16266997
[TBL] [Abstract][Full Text] [Related]
19. Decreased expression of the rat myometrial relaxin receptor (RXFP1) in late pregnancy is partially mediated by the presence of the conceptus.
Vodstrcil LA; Shynlova O; Verlander JW; Wlodek ME; Parry LJ
Biol Reprod; 2010 Nov; 83(5):818-24. PubMed ID: 20686184
[TBL] [Abstract][Full Text] [Related]
20. Development of a scaffold displaying exoloops of RXFP1.
Diepenhorst NA; Gooley PR; Stone MJ; Bathgate RA
Ital J Anat Embryol; 2013; 118(1 Suppl):1-3. PubMed ID: 24640555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
